Developer site: The content shown here is test data.

MyEClinic
MyEClinic
Health Dictionary AI Health Chat Find an Online Doctor
A serene Zen garden with raked sand and smooth stones, symbolising clarity and calm

Health Dictionary

Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.

Back to skin conditions

Anaphylaxis cost-effectiveness of therapy

Introduction

Overview

Overview

The current cost of auto-injectable epinephrine devices for the treatment of anaphylaxis are overpriced. [1]

Cost-effectiveness of Therapy

Cost-effectiveness of Therapy

Epinephrine is the mainstay of treatment for anaphylaxis and auto-injection expenses have increased in recent years. They are currently overpriced and this began with the increasing awareness of anaphylaxis. The recommendation was to keep 2 units of epinephrine on hand for each patient and the demand for the auto injection devices has created shortages which the FDA compensated for by extending its expiration dates to 2 years. It is recommended to lower the price as well as increase the device options to allow for competition among brands. [2] [1] [3] [4] [5]

References

References

  1. ↑ 1.0 1.1 Lieberman P, Nicklas RA, Randolph C, Oppenheimer J, Bernstein D, Bernstein J; et al. (2015). “Anaphylaxis–a practice parameter update 2015”. Ann Allergy Asthma Immunol. 115 (5): 341–84. doi:10.1016/j.anai.2015.07.019. PMID 26505932.
  2. ↑ Shaker M, Greenhawt M (2018). “Association of Fatality Risk With Value-Based Drug Pricing of Epinephrine Autoinjectors for Children With Peanut Allergy: A Cost-effectiveness Analysis”. JAMA Netw Open. 1 (7): e184728. doi:10.1001/jamanetworkopen.2018.4728. PMC 6324395. PMID 30646369.
  3. ↑ Rubin R (2016). “EpiPen price hike comes under scrutiny”. Lancet. 388 (10051): 1266. doi:10.1016/S0140-6736(16)31708-1. PMID 27673458.
  4. ↑ Simons FE, Ebisawa M, Sanchez-Borges M, Thong BY, Worm M, Tanno LK; et al. (2015). “2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines”. World Allergy Organ J. 8 (1): 32. doi:10.1186/s40413-015-0080-1. PMC 4625730. PMID 26525001.
  5. ↑ Cantrell FL, Cantrell P, Wen A, Gerona R (2017). “Epinephrine Concentrations in EpiPens After the Expiration Date”. Ann Intern Med. 166 (12): 918–919. doi:10.7326/L16-0612. PMID 28492859.

Template:WikiDoc Sources Cardiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Dushka Riaz, MD